Apellis Pharmaceuticals, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Fifth Avenue, Waltham, Massachusetts

Insiders trading volume in the past year

Apellis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $816 M Nov 18, 2021
Cedric Francois Chief Executive Officer, Director $145 M -$24.4 M -14.4% Mar 1, 2024
Pascal Deschatelets Chief Scientific Officer $51.1 M -$14.7 M -22.4% May 20, 2024
Alec Machiels Director $50.2 M -$314 K -0.62% Jan 1, 2024
Timothy Sullivan Chief Financial Officer $19.1 M -$1.92 M -9.16% Apr 18, 2024
Adam Townsend Chief Commercial Officer $8.55 M -$7.2 M -45.7% Feb 12, 2024
Lukas Scheibler Chief Research Officer $6.96 M -$676 K -8.85% Dec 1, 2023
Caroline Baumal Chief Medical Officer $6.17 M -$165 K -2.61% Jan 16, 2024
Federico Grossi Chief Medical Officer $6.04 M Jan 5, 2023
Jeffrey Eisele Chief Development Officer $5.63 M -$1.04 M -15.7% Jan 29, 2024
Nur Nicholson Chief Technical Officer $5.15 M -$1.89 M -26.9% Mar 13, 2024
Mark DeLong Chief Business & Strat Officer $4.75 M -$833 K -14.9% Mar 18, 2024
Karen Lewis Chief People Officer $4.68 M -$791 K -14.5% Jan 29, 2024
Sinclair Dunlop Director $4.31 M -$5.61 M -56.6% Jun 28, 2024
James Chopas VP/Chief Accounting Officer $3 M -$166 K -5.24% Mar 15, 2024
David Watson General Counsel $2.74 M -$890 K -24.5% Mar 6, 2024
Victoria Brown Program Team Lead $1.5 M Jan 20, 2023
Paul R. Fonteyne Director $1.43 M Jan 1, 2024
Gerald Chan Director $1.11 M Jan 1, 2024
Stephanie O'Brien Director $1.11 M Jan 1, 2024
Nicole Perry Vice President - Accounting $717 K Aug 2, 2021

Recent Insider Transactions by Companies or Individuals for Apellis Pharmaceuticals, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership